AZGP1 antibody

Catalog No. ABIN7634404

This Mouse Monoclonal antibody specifically detects AZGP1 in WB. It exhibits reactivity toward Rat.

Quick Overview for AZGP1 antibody (ABIN7634404)

Target: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Reactivity: Rat

Host: Mouse

Clonality: Monoclonal

Conjugate: This AZGP1 antibody is un-conjugated

Application: Western Blotting (WB)

Clone: C9

Product Details anti-AZGP1 Antibody

Purpose: Monoclonal Antibody to Alpha-2-Glycoprotein 1, Zinc Binding (aZGP1)

Specificity: The antibody is a mouse monoclonal antibody raised against aZGP1. It has been selected for its ability to recognize aZGP1 in immunohistochemical staining and western blotting.

Purification: Protein A + Protein G affinity chromatography

Immunogen: RPL231Ra01Recombinant Alpha2Glycoprotein 1, Zinc Binding (aZGP1)

Application Details

Application Notes: Western blotting: 0.01-5 μg/mL,Optimal working dilutions must be determined by end user.

Comment:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Target Details for AZGP1

Target: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Alternative Name: aZGP1

Background: ZA2G, ZAG

UniProt: Q63678

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process